Shaolin Ma
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- RNA modifications and cancer 2
-
- Respiratory Support and Mechanisms 3
- Pulmonary Hypertension Research and Treatments 2
- Prostate Cancer Treatment and Research 2
- Co-authors
- Liwu Fu (4 shared papers)Cristina Ivan (6 shared papers)Anil K. Sood (6 shared papers)Gabriel Lopez‐Berestein (5 shared papers)Cristian Rodriguez‐Aguayo (5 shared papers)Lingegowda S. Mangala (5 shared papers)Fang Wang (2 shared papers)Emine Bayraktar (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Oncotarget (3 papers)Oncogene (2 papers)iScience (1 paper)Brazilian Journal of Medical and Biological Research (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shaolin Ma
29 papers receiving 358 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 75
- Oncology 123
- Molecular Biology 199
- Reproductive Medicine 20
- Immunology 42
Countries citing papers authored by Shaolin Ma
This map shows the geographic impact of Shaolin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaolin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaolin Ma more than expected).
Fields of papers citing papers by Shaolin Ma
This network shows the impact of papers produced by Shaolin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaolin Ma. The network helps show where Shaolin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaolin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 2019 | 44 | |
| 3 | 2017 | 40 | |
| 4 | 2014 | 38 | |
| 5 | 2021 | 33 | |
| 6 | 2020 | 15 | |
| 7 | 2015 | 15 | |
| 8 | 2019 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2024 | 11 | |
| 11 | 2015 | 11 | |
| 12 | 2018 | 10 | |
| 13 | 2015 | 10 | |
| 14 | Impact of mitochondrial transcription factor A expression on the outcomes of ovarian, endometrial and cervical cancers. | 2020 | 10 |
| 15 | 2018 | 9 | |
| 16 | 2014 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2016 | 6 | |
| 19 | 2019 | 4 | |
| 20 | 2015 | 4 |
About Shaolin Ma
Shaolin Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Oncology, having authored 32 papers that have together received 363 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Respiratory Support and Mechanisms (3 papers), Sepsis Diagnosis and Treatment (3 papers), Pulmonary Hypertension Research and Treatments (2 papers), Prostate Cancer Treatment and Research (2 papers), RNA modifications and cancer (2 papers) and Dermatologic Treatments and Research (2 papers). The work is most often cited by research in Cancer Research (75 citations), Oncology (123 citations), Molecular Biology (199 citations), Reproductive Medicine (20 citations) and Immunology (42 citations). Shaolin Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Liwu Fu, Cristina Ivan, Anil K. Sood, Gabriel Lopez‐Berestein, Cristian Rodriguez‐Aguayo, Lingegowda S. Mangala, Fang Wang, Emine Bayraktar, Robert L. Coleman and Sherry Y. Wu. Their work appears in journals such as Molecular Cancer Therapeutics, Oncotarget, Oncogene, iScience and Brazilian Journal of Medical and Biological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.